Skip to main content
Clinical Trials/CTRI/2019/12/022332
CTRI/2019/12/022332
Not yet recruiting
未知

A study to evaluate the effectiveness of adding an oral second generation, non sedating, H1 antihistamine (Fexofenadine) to topical treatment in achieving better clinical outcome in paediatric patients of atopic dermatitis

PGIMER Chandigarh0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
PGIMER Chandigarh
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Paediatric patients of atopic dermatitis between 6months to 14 years of age, irrespective of sex diagnosed as per the UK criteria
  • Patients with mild to moderate disease
  • Willing to come for regular follow up

Exclusion Criteria

  • Patients with severe disease needing systemic therapy
  • Inability to come for follow up visits
  • Patients whose parents or guardians do not give valid consent

Outcomes

Primary Outcomes

Not specified

Similar Trials